The consistently lower JCHAIN mRNA expression in tumor samples compared to normal samples, in conjunction with its association with TNM staging and breast cancer subtypes, strongly suggests that JCHAIN is intricately involved in the biological processes that drive breast cancer progression. Here, JCHAIN is linked to breast cancer.